Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
Condition(s):ObesityLast Updated:March 1, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):ObesityLast Updated:March 1, 2021Withdrawn
Condition(s):Opioid-Related DisordersLast Updated:January 12, 2017Completed
Condition(s):Alcohol Dependence; VeteransLast Updated:October 24, 2011Terminated
Condition(s):MigraineLast Updated:March 19, 2024Not yet recruiting
Condition(s):Opioid Use Disorder; Alcohol Use DisorderLast Updated:March 19, 2019Completed
Condition(s):Biological AvailabilityLast Updated:May 19, 2011Completed
Condition(s):PainLast Updated:August 9, 2016Completed
Condition(s):Tobacco Use DisorderLast Updated:January 12, 2017Completed
Condition(s):AlcoholismLast Updated:April 8, 2020Completed
Condition(s):Pervasive Developmental DisorderLast Updated:May 3, 2006Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.